EBITDA multiples for specialty vet practices range from 4.5x to 7.5x depending on specialist depth, referral network quality, and margin profile.
Veterinary specialty practices — covering oncology, internal medicine, surgery, neurology, and cardiology — trade at premium multiples relative to general veterinary practices. PE-backed consolidators and SBA-financed individual buyers compete for practices with board-certified specialists, clean compliance records, and diversified referral networks. EBITDA margins of 15–25% are typical, with the highest multiples reserved for multi-specialist platforms with recurring chronic disease caseloads.
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Entry-Level / Single Specialist | $150K–$300K | 4.5x–5.5x | One board-certified specialist, limited referral diversification, aging equipment, or thin EBITDA margins under 18%. Higher transition risk. |
| Established Single-Discipline Practice | $300K–$500K | 5.5x–6.5x | Stable referral base across 10–20 GPs, strong specialist under contract, modern diagnostics, EBITDA margins of 18–22%. |
| Multi-Specialist or Multi-Discipline Practice | $500K–$900K | 6.5x–7.0x | Two or more board-certified specialists across disciplines, diversified referral network, recurring oncology or cardiology revenue, margins 22%+. |
| Premium Platform / Acquisition Target | $900K+ | 7.0x–7.5x | Full specialty hospital, 3+ specialists, owned real estate or long-term lease, PE-ready financials, dominant referral position in metro market. |
Specialist Retention & Contract Terms
High impactPractices with board-certified specialists on multi-year, assignable contracts with non-competes command meaningfully higher multiples. Single-specialist practices retiring at close face steep discounts.
Referral Network Diversification
High impactRevenue spread across 20+ referring GP practices reduces concentration risk. Over-reliance on one or two referring practices signals fragility and suppresses buyer confidence and pricing.
Diagnostic Equipment Condition
Medium impactOwned, recently upgraded MRI, CT, or endoscopy suites reduce near-term capex for buyers. Aging or unserviced equipment triggers price adjustments or earnout structures.
EBITDA Margin & Payor Mix
Medium impactMargins above 20% driven by high-value procedures attract premium multiples. Heavy reliance on pet insurance reimbursements with slow AR aging introduces valuation discounts.
Compliance & Licensing Cleanliness
Medium impactClean DEA controlled substance records, no state board complaints, and current OSHA compliance eliminate deal risk. Open violations can kill transactions or force significant price reductions.
PE-backed consolidators including Pathway Vet Alliance and National Veterinary Associates continue aggressively acquiring specialty practices, compressing cap rates and pushing multiples toward the 7x range for quality assets. Specialist shortages nationally are simultaneously increasing the leverage of employed veterinarians, making retention packages and earnout structures standard in nearly all 2023–2024 deals.
Two-specialist internal medicine and oncology practice in suburban Atlanta. Strong referral base, 22% EBITDA margin, modern CT suite owned outright.
$520K
EBITDA
6.8x
Multiple
$3.54M
Price
Single-specialist surgery practice in Denver metro. One board-certified surgeon on 3-year contract, 15 active referring GP relationships, $2.1M revenue.
$340K
EBITDA
5.8x
Multiple
$1.97M
Price
Three-specialist hospital (cardiology, neurology, surgery) in Dallas. PE add-on acquisition, dominant referral position, recurring chronic disease caseload, clean compliance records.
$920K
EBITDA
7.2x
Multiple
$6.62M
Price
EBITDA Valuation Estimator
Get your Veterinary Specialty Practice business value range instantly
Industry: Veterinary Specialty Practice · Multiples based on 5.5x–6.5x (Established Single-Discipline Practice)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Expect 4.5x–5.5x EBITDA. Single-specialist practices carry higher transition risk, and buyers price in contingency around retention. Long-term contracts and earnouts can improve pricing.
Yes. Most specialty vet practices qualify for SBA 7(a) loans covering 80–90% of purchase price. Lenders focus on specialist contract stability, referral revenue consistency, and clean DEA records.
If more than 30% of revenue comes from one or two referring practices, buyers discount multiples significantly. Documenting 20+ active referral relationships substantially increases perceived enterprise value.
PE consolidators pay 6.5x–7.5x because they underwrite synergies, shared services, and geographic network expansion. Individual SBA buyers typically cap at 5.5x–6.0x due to financing constraints.
More Veterinary Specialty Practice Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers